Vapotherm

📍 Exeter, United States🗓 Founded 1999👥 294 employees💰 Last funded May 2017
Vapotherm, Inc. is the inventor of high flow nasal cannula, and its advanced form: Vapotherm high velocity therapy. Delivering high velocity therapy, the Precision Flow® system offers clinicians a reliable tool for multiple patient populations. For respiratory distress patients presenting in the ED and ICU, high velocity therapy can provide not just oxygenation, but also Mask-Free NIV®—ventilatory support with the comfort of heated humidified high flow. Vapotherm, Inc. is a publicly traded company and listed on the NYSE under the ticker symbol "VAPO."
5
Total investors
0
Early stage
0
Mid stage
1
Late stage
1999
Founded
Investor geography1 country
United States
5
Investor activity2006–2017 · investors recorded per year
2006120091201312014120171
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Vapotherm?
Vapotherm has 5 investors on record on gritt.io and 1 late-stage investors.
When did Vapotherm last raise funding?
The most recent investment in Vapotherm recorded on gritt.io was in May 2017.
When was Vapotherm founded?
Vapotherm was founded in 1999.
What industry is Vapotherm in?
Vapotherm operates in Medical Equipment Manufacturing. Find similar Medical Equipment Manufacturing investors on gritt.io.
Where is Vapotherm based?
Vapotherm is headquartered in Exeter, United States.